Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black Men
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Prostate Cancer
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Enrollment
- 224
- Locations
- 3
- Primary Endpoint
- To establish the psychometric properties of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) in Black men with prostate cancer.
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
This study is being done to see if a standard tool used to check anxiety in white men works well for Black men. The tool is used only for men who have prostate cancer. It is meant to see how the cancer affects men. If the investigators have a good tool, it is more likely that the investigators can help those who have high levels of anxiety. This test is known as the Memorial Anxiety Scale for Prostate Cancer (also called the MAX-PC).
Investigators
Eligibility Criteria
Inclusion Criteria
- •18 years of age or older
- •Patients who are being monitored by PSA tests, who will have a PSA test done on the day of their current clinic visit or prior to their clinic visit, but prior to being informed of the results
- •Diagnosis of prostate cancer
- •Ethnicity: Black, African-American, or of African descent (and will include those men who identify as Black and Hispanic).
- •Ability to comprehend and complete questionnaires in English
Exclusion Criteria
- •Major psychopathology or cognitive impairment likely, in the judgment of the research staff, to interfere with the participation or completion of the protocol
- •Other non-Black or non-African-American ethnic groups
Outcomes
Primary Outcomes
To establish the psychometric properties of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) in Black men with prostate cancer.
Time Frame: within one to three weeks of receiving their PSA scores from their physician
Secondary Outcomes
- To explore the prevalence of distress, anxiety, and depression in Black men with prostate cancer.(within one to three weeks of receiving their PSA scores from their physician)